« Back
Home /
PLA2G16 Antibody

PLA2G16 Antibody

Item no.	CSB-PA018089HA01HU-50ug
Manufacturer	Cusabio
Amount	50ug
Category	Oncology Metabolism Cholesterol & Lipid Metabolism Antibodies By Cell Type Carcinoma Cell Biology Cytoskeleton ELISA Cardiovascular Research Thrombosis & Hemostasis Enzymes Fatty Acid Catabolism Primary Antibodies small GTPases Miro Subfamily
Type	Antibody Polyclonal
Format	Liquid
Applications	ELISA
Specific against	Human
Host	Rabbit
Isotype	IgG
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	Adipose specific phospholipase A2 antibody; Adipose specific PLA2 antibody; Adipose-specific phospholipase A2 antibody; AdPLA antibody; Ca independent phospholipase A1/2 antibody; Group XVI phospholipase A1/A2 antibody; Group XVI phospholipase A2 antibody; H rev 107 protein homolog antibody; H REV107 1 antibody; H-rev 107 protein homolog antibody; HRAS like suppressor 1 antibody; HRAS like suppressor 3 antibody; HRAS-like suppressor 1 antibody; HRAS-like suppressor 3 antibody; HREV107 1 antibody; HREV107 3 antibody; HREV107 antibody; HREV107-1 antibody; HREV107-3 antibody; HRSL3 antibody; HRSL3_HUMAN antibody; Phospholipase A2 group XVI antibody; Pla2g16 antibody; Renal carcinoma antigen NY REN 65 antibody; Renal carcinoma antigen NY-REN-65 antibody, HRAS-like suppressor 3 (HRSL3) (EC 3.1.1.32) (EC 3.1.1.4) (Adipose-specific phospholipase A2) (AdPLA) (Group XVI phospholipase A1/A2) (H-rev 107 protein homolog) (H-REV107) (HREV107-1) (HRAS-like suppressor 1) (HREV107-3) (Renal carcinoma antigen NY-REN-65), PLA2G16, HRASLS3 HREV107
Similar products	PLA2G16, HRAS-like suppressor 3 (HRSL3) (EC 3.1.1.32) (EC 3.1.1.4) (Adipose-specific phospholipase A2) (AdPLA) (Group XVI phospholipase A1/A2) (H-rev 107 protein homolog) (H-REV107) (HREV107-1) (HRAS-like suppressor 1) (HREV107-3) (Renal carcinoma antigen NY-REN-6, HRASLS3 HREV107
Available
Immunogen Species	Human
UniprotID	P53816
Immunogen	Recombinant Human HRAS-like suppressor 3 protein (1-132AA)
Applications info	ELISA
Background	Exhibits PLA1/2 activity, catalyzing the calcium-independent hydrolysis of acyl groups in various phosphatidylcholines (PC) and phosphatidylethanolamine (PE). For most substrates, PLA1 activity is much higher than PLA2 activity. Specifically catalyzes the release of fatty acids from phospholipids in adipose tissue (By similarity). N- and O-acylation activity is hardly detectable. Might decrease protein phosphatase 2A (PP2A) activity.
Conjugate	Non-conjugated
Buffer	Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Storage	Upon receipt, store at -20C or -80C. Avoid repeated freeze.
Purification Method	>95%, Protein G purified
General Research Areas	Cancer
Initial Research Areas	Cancer

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

CSB-PA018089HA01HU-50ug-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 50ug

available

Delivery expected until 9/13/2024

Express Delivery: Save 3 days

Compare

Add to wishlist

Recommend by mail